Eeva Taimela, MD PhD
Bäch
Summary
Strong Medical Affairs Executive and analytical problem-solver with talents for team building, leading and motivating, as well as excellent customer relations aptitude and relationship-building skills.
Proficient in using independent decision-making skills and sound judgment to positively impact company success.
Dedicated to applying training, monitoring and morale-building abilities to enhance employee engagement and boost performance.
Overview
33
33
years of professional experience
Work History
Global Director, BEO Medical Excellence
Novartis Oncology
01.2021 - 01.2024
- Launched training programs for employees worldwide, enhancing skillsets and career development opportunities within the company.
- Enhanced global operations by streamlining communication channels and implementing efficient collaboration tools.
Head of Global Medical Affairs Capability Building
AAA, a Novartis Company
01.2019 - 01.2021
- Self-motivated, with a strong sense of personal responsibility.
- Worked effectively in fast-paced environments.
- Proved successful working within tight deadlines and a fast-paced environment.
- Demonstrated strong organizational and time management skills while managing multiple projects.
- Enhanced global operations by streamlining communication channels and implementing efficient collaboration tools.
- Cultivated strong relationships with stakeholders at all levels of the organization to facilitate smooth execution of projects.
- Launched training programs for employees worldwide, enhancing skillsets and career development opportunities within the company.
- Provided leadership and guidance to multicultural teams, promoting a positive work environment and employee engagement.
Head of Global Medical Affairs Competency Development
Hoffmann-La Roche
01.2014 - 01.2019
- Established and enhanced the leadership and learning curriculum for the Global Medical Network with close collaboration with HR.
- Built a high-performing team, focusing on continuous learning and professional development opportunities.
- Established strong relationships with key stakeholders to gain an in-depth understanding of business needs and priorities.
- Managed vendor relationships effectively, ensuring high-quality service delivery from third-party agencies.
Global Medical Affairs Head Training & Medical Standards
Hoffmann-La Roche
01.2012 - 01.2014
- Created, branded and launched the Affiliate Passport, the global compliance and performance tool for Medical Affairs teams in Affiliates
- Created the Digital Onboarding for Global Medical Affairs
- Created the functional competency framework (eagle) for Global Medical Network, which was consequently adopted to all other PD functions
- Supported staff members in their daily tasks, reducing workload burden and allowing for increased focus on higher-priority assignments.
- Monitored team performance and provided constructive feedback to increase productivity and maintain quality standards.
- Built strong relationships with customers through positive attitude and attentive response.
- Empowered team members by delegating responsibilities according to individual strengths and areas of expertise.
Global Medical Affairs Training & Medical Standards Leader
Hoffmann-La Roche
01.2010 - 01.2012
- Enhanced employee performance by developing and implementing comprehensive training programs.
- Assessed additional needs based on training progress and collaborated with management to meet requirements.
- Promoted a culture of continuous improvement by conducting regular follow-ups with trainees post-training sessions.
Country Medical Director
Roche Oy
01.2007 - 01.2010
- Supervised Medical Affairs staff, providing continuous professional development opportunities and training to maintain and strengthen competencies.
- Managed multidisciplinary teams, fostering collaboration between various healthcare professionals for optimal patient care.
- Developed quarterly and yearly objectives, goals and budgets in addition to devising suggestions to decrease spending.
- Drove planning for business development and relationship building with healthcare partners.
- Championed a culture of continuous learning within the organization, encouraging staff to pursue ongoing education opportunities relevant to their roles.
- Oversaw clinical trials, ensuring compliance with regulatory requirements and ethical standards.
- Optimized resource allocation by analyzing departmental budgets and reallocating funds where necessary for maximum impact on patient care.
- Recruited, hired and trained all staff, providing direct supervision, ongoing staff development and continuing education to employees.
Medical Advisor
Roche Oy
01.2005 - 01.2007
- Provided authoritative opinion and expertise to medical-based questions from internal personnel to comply with statutory requirements.
- Led successful publication planning efforts by collaborating with external authors and managing submission timelines.
- Developed innovative strategies for maximizing patient access to life-changing therapies, improving overall health outcomes.
Nordic Medical Adviser
Novartis Oncology
01.2002 - 01.2005
- Established a wide PhIIIb/IV program for the oncology portfolio in Finland and Nordic countries
- Led Nordic Advisory Boards
- Member of local Medical Affairs Leadership Team.
- Self-motivated, with a strong sense of personal responsibility.
- Skilled at working independently and collaboratively in a team environment.
- Worked effectively in fast-paced environments.
- Proven ability to learn quickly and adapt to new situations.
- Worked flexible hours across night, weekend, and holiday shifts.
- Used critical thinking to break down problems, evaluate solutions and make decisions.
- Proved successful working within tight deadlines and a fast-paced environment.
Medical Adviser
Health Economics and Scientific Evaluation, Orion Pharma
01.2000 - 01.2002
- As a joint venture with Novartis, led the entacapone health economic model creation / Parkinson's
- Analysed the results of Health Economic studies, built the Markov model, wrote publications and gave presentation at Novartis symposium at an International Parkinson's congress.
- Drafted and analyzed complex medical data.
- Conducted scientific and clinical presentations to facilitate medical education strategy.
Clinical Research Physician
Orion Pharma
01.1998 - 01.2000
- Work in PhI studies, and medical writing of documents for authorities.
- Generated and maintained reports, listings and trackers.
- Facilitated communication between internal stakeholders and external collaborators, streamlining project coordination efforts.
Medical Doctor
Finnish Red Cross Blood Transfusion Service
01.1994 - 01.1998
- Haemostasis and transfusion medicine consultant for all national hospitals.
- Maintained high levels of laboratory safety by adhering to strict guidelines and conducting regular safety audits.
- Enhanced laboratory efficiency by implementing standardized testing procedures and protocols.
- Utilized expertise in microbiology, chemistry, and hematology to help with diagnosis of medical issues.
- Participated in interdisciplinary team meetings, sharing insights from lab findings to inform treatment decisions.
- Collaborated with healthcare professionals to provide comprehensive patient care and improve treatment outcomes.
- Collaborated with other departments to develop cross-functional educational programs that bridged gaps in knowledge and facilitated interdisciplinary collaboration.
Medical Doctor
Central Laboratory, Turku University Central Hospital
01.1991 - 01.1994
- Work in different clinical laboratories, establishing collaboration between laboratory medicine and various clinical specialties
- PhD in endocrinology area (time-resolved immunofluorometric assay methodology).
Education
Executive Education in Management -
Aalto University
HelsinkiSpecialist Physician Clinical Chemistry -
University of Turku
Dr of Medical Sciences (Ph.D.) -
University of Turku
M.D. -
University of Turku
Skills
- Inspirational Leadership
- Strategic Planning
- Business Development
- Problem Resolution
- Training and Development
- Customer-Oriented
- Project Management
- Networking abilities
Citizenships
Nationality: Finnish and Swiss Citizen
Languages
Finnish
Proficient
C2
English
Proficient
C2
German
Intermediate
B1
Swedish
Upper intermediate
B2
Career Summary
- Global Director, BEO Medical Excellence, Novartis Oncology, Basel, 2021 - 2024
- Head of Global Medical Affairs Capability Building, AAA, a Novartis Company, Geneva, 2019 - 2021
- Head of Global Medical Affairs Competency Development, Hoffmann-La Roche, Basel, 2014 - 2019
- Global Medical Affairs Head Training & Medical Standards, Hoffmann-La Roche, Basel, 2012 - 2014
- Global Medical Affairs Training & Medical Standards Leader, Hoffmann-La Roche, Basel, 2010 - 2012
- Country Medical Director, Roche Oy, Finland, 2007 - 2010
- Medical Advisor, Roche Oy, Finland, 2005 - 2007
- Nordic Medical Adviser, Novartis Oncology, Finland, 2002 - 2005
- Medical Adviser, Health Economics and Scientific Evaluation, Orion Pharma, Finland, 2000 - 2002
- Clinical Research Physician, Orion Pharma, Espoo, Finland, 1998 - 2000
- Medical Doctor, Finnish Red Cross Blood Transfusion Service, Helsinki, Finland, 1994 - 1998
- Medical Doctor, Central Laboratory, Turku University Central Hospital, Turku, Finland, 1991 - 1994
Abstracts
- Quality of life and cost-of-illness in Parkinson's disease. Update status of the EcoPD study, Moving Forward in the Management of Parkinson's Disease, Crete, 2000
- Quality of life and cost-of-illness are significantly associated with Parkinson's disease severity; a naturalistic patient management setting in Finland, 5th Congress of the European Federation of Neurological Sciences, Denmark, 2000
- Economic Burden and Quality of Life are Associated with Parkinson's Disease Severity - A Naturalistic Patient Management Setting in Finland, The 53rd Annual Meeting of the American Academy of Neurology, Philadelphia, USA, 2001
- Economic burden and quality of life impairment increase with severity of Parkinson's disease - a health economic study, XIV International Congress on Parkinson's Disease, Helsinki, Finland, 2001
- Reduced costs and better quality of life with entacapone treatment - a cost-utility analysis in Parkinson's disease, XIV International Congress on Parkinson's Disease, Helsinki, Finland, 2001
- Entacapone combined with levodopa: is it cost-effective in all Parkinson's disease patients on levodopa, XIV International Congress on Parkinson's Disease, Helsinki, Finland, 2001
Publications
- Clinical and laboratory studies of new time-resolved fluorescence immunoassays for thyrotropin (hTSH) and free triiodothyronine (FT3), Clinical Chemistry, 1993
- Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH, Clinical Chemistry, 1994
- Time-resolved immunofluorometric assay for thyrotropin improved for enhanced functional sensitivity and clinical discrimination, Scandinavian Journal of Clinical & Laboratory Investigation, 1994
- Free thyroid hormones and a third generation TSH assay in the detection of subclinical hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients, Scandinavian Journal of Clinical & Laboratory Investigation, 1995
- Accelerated bone degradation in thyroid carcinoma patients during thyroxine treatment measured with serum carboxyterminal telopeptide region of type I collagen (ICTP), European journal of Clinical Chemistry and Clinical Biochemistry, 1994
- Laboratory and Clinical studies of third generation time-resolved immunofluorometric assay for thyrotropin, Dissertation Thesis, Unversity of Turku, 1995
- Third generation immunofluorometric TSH assay for automatic immunoassay system evaluated, Scandinavian Journal of Clinical & Laboratory Investigation, 1995
- Reference intervals for serum thyrotropin, free thyroxine and free triiodothyronine in healthy adults in Finland, measured by an immunoautomate based on time-resolved fluorescence (AutoDELFIAR), European Journal of Clinical Chemistry and Clinical Biochemistry, 1997
- Anemia kiinteiden syöpäkasvainten yhteydessä, Duodecim, 2007
- Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours, Support Care Cancer, 2010
Timeline
Global Director, BEO Medical Excellence
Novartis Oncology
01.2021 - 01.2024
Head of Global Medical Affairs Capability Building
AAA, a Novartis Company
01.2019 - 01.2021
Head of Global Medical Affairs Competency Development
Hoffmann-La Roche
01.2014 - 01.2019
Global Medical Affairs Head Training & Medical Standards
Hoffmann-La Roche
01.2012 - 01.2014
Global Medical Affairs Training & Medical Standards Leader
Hoffmann-La Roche
01.2010 - 01.2012
Country Medical Director
Roche Oy
01.2007 - 01.2010
Medical Advisor
Roche Oy
01.2005 - 01.2007
Nordic Medical Adviser
Novartis Oncology
01.2002 - 01.2005
Medical Adviser
Health Economics and Scientific Evaluation, Orion Pharma
01.2000 - 01.2002
Clinical Research Physician
Orion Pharma
01.1998 - 01.2000
Medical Doctor
Finnish Red Cross Blood Transfusion Service
01.1994 - 01.1998
Medical Doctor
Central Laboratory, Turku University Central Hospital
01.1991 - 01.1994
Executive Education in Management -
Aalto University
Specialist Physician Clinical Chemistry -
University of Turku
Dr of Medical Sciences (Ph.D.) -
University of Turku
M.D. -
University of Turku
Similar Profiles
Jack ThomasonJack Thomason
AD, Strategic Account Manager, Cellular Therapy at Novartis OncologyAD, Strategic Account Manager, Cellular Therapy at Novartis Oncology
Trina OnealTrina Oneal
Oncology Sales Specialist at Novartis OncologyOncology Sales Specialist at Novartis Oncology
Kimberly Ann PierwolaKimberly Ann Pierwola
Hematology Sales Specialist at NOVARTIS ONCOLOGYHematology Sales Specialist at NOVARTIS ONCOLOGY